BMO Capital lowered the firm’s price target on Global Medical REIT (GMRE) to $7.50 from $9.50 and keeps a Market Perform rating on the shares. The firm made changes to its models for a number of REITs due to interest rate changes, recent results, and/or discussions with company management.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMRE:
- Global Medical REIT Holds Annual Stockholder Meeting
- Global Medical REIT Reports Steady Q1 2025 Results
- Global Medical REIT Inc’s Mixed Earnings Call Insights
- Global Medical REIT price target lowered to $9.50 from $11 at Alliance Global Partners
- Global Medical REIT price target lowered to $9 from $10 at Baird